Meinardi H, Scott R A, Reis R, Sander J W
Department of Physiology, Leyden University Medical Centre, P.O. Box 9604, 2300 RC Leiden, The Netherlands.
Epilepsia. 2001 Jan;42(1):136-49. doi: 10.1046/j.1528-1157.2001.32800.x.
This article is a summary of a workshop held by the ILAE concerning the issue of the epilepsy treatment gap in developing countries. The gap is defined in terms of those people with epilepsy who are not being appropriately treated and is the result of an array of medical, political, social, economic, and cultural factors. The situation regarding the treatment gap for various countries is reviewed, along with some of its causes. Although the overall gap is estimated to be large, a number of recent projects and interventions have been effective in delivering appropriate treatment to people with epilepsy in underresourced countries of the developing world. It is hoped that these may be transferable elsewhere and that, combined with the ILAE/IBE/WHO Global Campaign against Epilepsy and increased support from the worldwide epilepsy community, the treatment gap will begin to be bridged.
本文是国际抗癫痫联盟（ILAE）举办的一次研讨会的总结，该研讨会围绕发展中国家癫痫治疗缺口问题展开。这一缺口是指未得到适当治疗的癫痫患者，它是一系列医学、政治、社会、经济和文化因素造成的结果。文中回顾了各国治疗缺口的情况及其部分成因。尽管总体缺口估计很大，但最近一些项目和干预措施已有效地为发展中世界资源匮乏国家的癫痫患者提供了适当治疗。希望这些措施能推广到其他地方，并且，结合国际抗癫痫联盟/国际癫痫局/世界卫生组织全球抗癫痫运动以及全球癫痫界更多的支持，治疗缺口将开始得到弥合。
